Cited in:


This article has been cited by:

  1. 1
    M El Assar, J M Sánchez-Puelles, I Royo, E López-Hernández, A Sánchez-Ferrer, J L Aceña, L Rodríguez-Mañas, J Angulo, FM19G11 reverses endothelial dysfunction in rat and human arteries through stimulation of the PI3K/Akt/eNOS pathway, independently of mTOR/HIF-1α activation, British Journal of Pharmacology, 2015, 172, 5
  2. 2
    Teresa Valdes-Sánchez, Francisco Javier Rodriguez-Jimenez, Dunia M. García-Cruz, Jorge L. Escobar-Ivirico, Ana Alastrue-Agudo, Slaven Erceg, Manuel Monleón, Victoria Moreno-Manzano, Methacrylate-endcapped caprolactone and FM19G11 provide a proper niche for spinal cord-derived neural cells, Journal of Tissue Engineering and Regenerative Medicine, 2015, 9, 6
  3. 3
    Yona Goldshmit, Frisca Frisca, Alexander R. Pinto, Alice Pébay, Jean-Kitty K. Y. Tang, Ashley L. Siegel, Jan Kaslin, Peter D. Currie, Fgf2 improves functional recovery—decreasing gliosis and increasing radial glia and neural progenitor cells after spinal cord injury, Brain and Behavior, 2014, 4, 2
  4. You have free access to this content4
    Marcelo G. Bonini, Benjamin N. Gantner, The multifaceted activities of AMPK in tumor progression—why the “one size fits all” definition does not fit at all?, IUBMB Life, 2013, 65, 11